Clinical Trial Update: A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of tildacerfont in females with Polycystic Ovary Syndrome and elevated adrenal androgens was terminated. Results fr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Tildacerfont (tildacerfont)

Snippet

Sponsor: Spruce Biosciences | Conditions: Polycystic Ovary Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2025-10-09